Fairvoy Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Buy
6,243
+606
+11% +$160K 0.33% 68
2026
Q2
$1.43M Buy
5,637
+428
+8% +$100K 0.29% 77
2026
Q1
$1.27M Sell
5,209
-12
-0.2% -$2.8K 0.3% 78
2025
Q4
$1.08M Buy
5,221
+42
+0.8% +$8.3K 0.24% 87
2025
Q3
$960K Buy
5,179
+3,680
+245% +$630K 0.22% 93
2025
Q2
$229K Sell
1,499
-124
-8% -$19.1K 0.06% 176
2025
Q1
$269K Buy
1,623
+6
+0.4% +$939 0.07% 153
2024
Q4
$234K Buy
+1,617
New +$251K 0.06% 166

Other funds holding JNJ

Fairvoy Private Wealth's JNJ Position: Q3 2026 in Review

Fairvoy Private Wealth increased its Johnson & Johnson (JNJ) stake by 11% in Q3 2026, buying an estimated $160K and bringing the position to 6,243 shares worth $1.65M. The position accounts for 0.33% of the portfolio, ranked #68.

Fairvoy Private Wealth first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,709 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Fairvoy Private Wealth held 6,243 shares of Johnson & Johnson worth $1.65M as of Q3 2026.
  • Fairvoy Private Wealth bought 606 Johnson & Johnson shares in Q3 2026, an estimated $160K.
  • Johnson & Johnson made up 0.33% of Fairvoy Private Wealth's portfolio in Q3 2026, its #68 holding.
  • Fairvoy Private Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,709 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.